mfresearch ๐Ÿ”’ Show amounts

HDFC Pharma and Healthcare Fund - Direct Plan - Growth Option

code 152082 Sectoral/Thematic direct plan ยท growth NAVs 2023-10-04 to 2026-11-09

Benchmark: BSE HEALTHCARE proxy 152844 declared: AMFI Fund Performance (Fund-Performance-30-Sep-2026--2032.xlsx), as of 2026-09-30 Compare with:

Growth of โ‚น10,000 vs benchmark

From 2024-09-09, common dates. Scroll or drag to zoom.

Drawdown

Rolling 1-year CAGR

Returns

periodfundfund*benchmark*fund โˆ’ benchmark*from โ†’ to
1M8.84% 8.84%8.69% 0.15% 2026-10-09 โ†’ 2026-11-09
3M5.75% 5.75%3.55% 2.20% 2026-08-07 โ†’ 2026-11-09
6M19.02% 19.02%14.23% 4.79% 2026-05-08 โ†’ 2026-11-09
1Y31.91% 31.91%19.71% 12.21% 2025-11-07 โ†’ 2026-11-09
3Y31.39% -- - 2023-11-09 โ†’ 2026-11-09
5Y- -- -
7Y- -- -
10Y- -- -
since inception31.81% 19.17%9.99% 9.19% 2023-10-04 โ†’ 2026-11-09

Absolute under 1 year, CAGR from 1 year. * Common dates only.

Calendar years

year20242025
fund52.22%2.42%
benchmark--2.98%

Rolling returns

lengthperiodsaveragemedianworstbest% positive% beating benchmark
1 year28715.68%16.56% 1.71%31.91%100% 100%

Risk and risk-adjusted return

3 years
2023-11 โ€“ 2026-10
CAGR30.57%
volatility16.13%
max drawdown-14.91%
downside deviation8.38%
Sharpe ratio1.39
Sortino ratio2.66
Calmar ratio2.05
alpha (annualised)-
beta-
Rยฒ-
tracking error-
information ratio-
up / down capture-
Treynor ratio-
36 months: benchmark lacks some months of the window: no relative metrics
Sector/theme fund: not ranked. Compare with its benchmark above.

Add to comparison โ†’